Clashes break out at French cost-of-living protests as turnout falls
Police fired tear gas at protesters in several French cities on Saturday (21 November), although turnout at the latest day of demonstrations o...
Indian police have arrested the owner of Sresan Pharmaceutical Manufacturer, the cough syrup company linked to the deaths of at least 19 children in the central state of Madhya Pradesh, a senior police officer told Reuters on Thursday.
The children, all under five years of age, died in the past month in the state's Chhindwara city, after consuming cough medicine containing toxic diethylene glycol in quantities nearly 500 times the permissible limit.
The deaths were all linked to Sresan Pharma's Coldrif syrup, which has been banned in several parts of India after a test confirmed the presence of the chemical last Thursday.
SYRUP FACTORY OWNER ARRESTED
S.Ranganathan, owner of the Tamil Nadu state-based company that manufactured the syrup, was arrested on Wednesday in Chennai where he will appear in court before being moved to Chhindwara, the Chhindwara Superintendent of Police Ajay Pandey told Reuters.
Local drug authorities have stepped up efforts to curb the circulation of contaminated medicine, testing random samples of cough syrups and making door-to-door calls to retrieve Coldrif bottles,
"We (have) got 30-40 bottles (through this means)...we (also) recalled some from retailers and stockists," district administrator Harendra Narayan said, adding that 594 bottles of the syrup were sold to pharmaceutical stockists in the region over the last six weeks.
By law, Indian drugmakers must test each batch of raw materials and the final product.
Exports of cough syrup require another layer of tests at government-mandated laboratories since 2023, after the deaths of over 10 children in Gambia, Uzbekistan and Cameroon were linked to Indian syrups.
The World Health Organization has said the recent case highlights a "regulatory gap" in India’s screening of medicines being sold domestically, and warned that some exports could have been made unofficially.
Indian authorities have asked people to avoid two other locally-sold syrups, Respifresh and RELIFE, made by Gujarat state-based Shape Pharma and Rednex Pharmaceuticals, after tests found they contained the same toxic chemical
Known as the "pharmacy of the world", India is the third-largest drug producer by volume after the U.S. and China.
The country supplies 40% of generic medicines used in the U.S., and more than 90% of all medicines in many African nations.
U.S. President Donald Trump has said China agreed for the first time to join trilateral talks on reducing nuclear risk at this week’s summit with Russia’s Vladimir Putin and China’s Xi Jinping.
Iran's Foreign Minister, Abbas Araghchi has said Tehran still hopes to end its war with the U.S. through diplomacy. It comes after U.S. President Donald Trump said the deal Iran wanted was not one he could accept.
The International Court of Justice (ICJ) is the United Nations’ highest court. Known as the World Court, it is the only international court where countries take each other to court over breaches of international law.
At least four people have been killed and 30 injured in a fire at a power station in the southern Iraqi city of Basra. The death toll from the blaze on Saturday (21 November) is expected to rise, security officials said.
Students and workers took to the streets across Europe on Friday, 20 November, demanding better pay, affordable housing and more funding for education and public services, while protesting against rising military spending.
For the first time in more than a quarter of a century, the United States can no longer say it has eliminated measles as health experts warn the American outbreak reflects a collapse in trust in vaccines.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment